Advancing the Benefits of
Cannabinoid Therapy

The use of cannabis for medical purposes can be traced back centuries. Cannabidiol (CBD) and tetrahydrocannabinol (THC) are the two primary active cannabinoids in cannabis. Both cannabinoids have been studied for their medical utility.


Advancing the Understanding of CBD-Based Medication

At GRx, we are establishing global partnerships among healthcare practitioners to guide the development and adoption of CBD-based medications within practice guidelines and conducting clinical trials that add to the growing body of evidence in support of the efficacy of cannabinoid therapy in select patient populations.





Individualized Products

CBD interacts with the endocannabinoid system (ECS) and is known to offer a range of potential health benefits. The ECS regulates the activity of neurotransmitters that react with receptors found in the central nervous system (CNS), cardiovascular system, liver, skeletal muscle and adipose tissue. To meet the individualized needs of patients, Green Relief products offer varying CBD:THC ratios.


For safe and reliable dosing, each Green Relief product is backed by a laboratory-issued Certificate of Analysis (CoA) providing accurate cannabinoid potencies.

Clean & Green

Green Relief cultivates cannabis using a sustainable form of agriculture called aquaponics, which combines aquaculture (raising fish) with hydroponics (growing plants in water) to form a balanced ecosystem.


Our cannabinoid medications are produced through supercritical CO2 extraction, a process that extracts cannabinoids from plant matter. The result is a high-quality medical product.